IL-10 synergistically enhances GM-CSF-induced CCR1 expression in myelomonocytic cells

Biochemical and Biophysical Research Communications

Volumn 304, Issue 2, 2003, Pages 417-424

  Li, Hui ^a   Cheung, Wai ^b   Choo, Hui Hwa ^a   Chan, Jasmine H P ^a   Lai, Poh San ^b   Fred Wong, W S ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

CCR1; GM CSF; IL 10; LY294002; MIP 1 ; p70S6k; PD098059; PKB Akt; U0126; U937

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CHEMOKINE RECEPTOR CCR1; GENISTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; PROTEIN P70; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 10;

ARTICLE; CELL STRAIN U937; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MONOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 0344950490     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00612-0     Document Type: Article

References (38)

1. Olson T.S., Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regulat. Integrative Comp. Physiol. 283:2002;R7-R28.
2. Trebst C., Sorensen T.L., Kivisakk P., Cathcart M.K., Hesselgesser J., Horuk R., Sellebjerg F., Lassmann H., Ransohoff R.M. CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am. J. Pathol. 159:2001;1701-1710.
3. Tokuda A., Itakura M., Onai N., Kimura H., Kuriyama T., Matsushima K. Pivotal role of CCR1-positive leukocytes in bleomycin-induced lung fibrosis in mice. J. Immunol. 164:2000;2745-2751.
4. Gerard C., Frossard J.L., Bhatia M., Saluja A., Gerard N.P., Lu B., Steer M. Targeted disruption of the β-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J. Clin. Invest. 100:1997;2022-2027.
5. Rottman J.B., Slavin A.J., Silva R., Weiner H.L., Gerard C.G., Hancock W.W. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur. J. Immunol. 30:2000;2371-2377.
6. Gao W., Topham P.S., King J.A., Smiley S.T., Csizmadia V., Lu B., Gerard C.J., Hancock W.W. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J. Clin. Invest. 105:2000;35-44.
7. -/- mice during chronic fungal allergic airway disease J. Immunol. 165:2000;1564-1572.
8. Moore K.W., De Waal Malefyt R., Coffman R.L., O'garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:2001;683-765.
9. Hamilton J.A. GM-CSF in inflammation and autoimmunity. Trends Immunol. 23:2002;403-408.
10. Mocellin S., Panelli M.C., Wang E., Nagorsen D., Marincola F.M. The dual role of IL-10. Trends Immunol. 24:2003;36-43.
11. Sozzani S., Ghezzi S., Iannolo G., Luini W., Borsatti A., Polentarutti N., Sica A., Locati M., Mackay C., Wells T.N.C., Biswas P., Vicenzi E., Poli G., Mantowani A. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J. Exp. Med. 187:1998;439-444.
12. Jarmin D.I., Nibbs R.J.B., Jamieson T., De Bono J.S., Graham G.J. Granulocyte-macrophage colony-stimulating factor and interleukin-3 regulate chemokine and chemokine receptor expression in bone marrow macrophages. Exp. Hematol. 27:1999;1735-1745.
13. Sato K., Kawasaki H., Nagayama H., Serizawa R., Ikeda J., Morimoto C., Yasunaga K., Yamaji N., Tadokoro K., Juji T., Takahasi T.A. CC chemokine receptors, CCR-1 and CCR-3, are potentially involved in antigen-presenting cell function of human peripheral blood monocyte-derived dendritic cells. Blood. 93:1999;34-42.
14. Campbell I.K., Rich M.J., Bischof R.J., Dunn A.R., Grail D., Hamilton J.A. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 161:1998;3639-3644.
15. Mcqualter J.L., Darwiche R., Ewing C., Onuki M., Kay T.W., Hamilton J.A., Reid H.H., Bernard C.C. Granulocyte-macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194:2001;873-882.
16. Kitching A.R., Ru Huang X., Turner A.L., Tipping P.G., Dunn A.R., Holdsworth S.R. The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury. J. Am. Soc. Nephrol. 13:2002;350-358.
17. Lee C.G., Homer R.J., Cohn L., Link H., Jung S., Craft J.E., Graham B.S., Johnson T.R., Elias J.A. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J. Biol. Chem. 277:2002;35466-35474.
18. Cavaillon J.M. Pro-versus anti-inflammatory cytokines: myth or reality. Cell Mol. Biol. 47:2001;695-702.
19. Li W., Fu F., Lu L., Narula S.K., Fung J.J., Thomson A.W., Qian S.S. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Transplantation. 66:1988;1587-1596.
20. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179:1994;305-310.
21. Llorente L., Zou W., Levy Y., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Morel-Fourrier B., Brouet J.C., Alarcon-Segovia D., Galanaud P. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181:1995;839-844.
22. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
23. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:1998;18623-18632.
24. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:1994;5241-5248.
25. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S.I., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinase. J. Biol. Chem. 262:1997;5592-5595.
26. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J. Biol. Chem. 271:1996;695-701.
27. Chang L., Karin M. Mammalian MAP kinase signaling cascades. Nature. 410:2001;37-40.
28. Toker A. Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol. Pharmcol. 57:2000;652-658.
29. Shah O.J., Anthony J.C., Kimball S.R., Jefferson L.S. 4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle. Am. J. Physiol. Endocrinol. Metab. 279:2000;E715-E729.
30. Alessi D.R., Kozlowski M.T., Weng Q.P., Morrice N., Avruch J. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70S6 kinase in vivo and in vitro. Curr. Biol. 8:1997;69-81.
31. Mui A.L., Wakao H., Harada N., O'farrell A.M., Miyajima A. Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5. J. Leukoc. Biol. 57:1995;799-803.
32. Kwon E.M., Sakamoto K.M. The molecular mechanism of action of granulocyte-macrophage colony-stimulating factor. J. Invest. Med. 44:1996;442-446.
33. Liu R., Itoh T., Arai K., Watanabe S. Two distinct signaling pathways downstream of janus kinase 2 play redundant roles for antiapoptotic activity of granulocyte-macrophage colony-stimulating factor. Mol. Biol. Cell. 10:1999;3959-3970.
34. mapk are involved in IL-10-mediated selective repression of TNF-α-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells J. Immunol. 162:1999;3865-3872.
35. Donnelly R.P., Dickensheets H., Finbloom D.S. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J. Interferon Cytokine Res. 19:1999;563-573.
36. Riley J.K., Takeda K., Akira S., Schreiber R.D. Interleukin-10 receptor signaling through the JAK-STAT pathway. J. Biol. Chem. 274:1999;16513-16521.
37. Crawley J.B., Williams L.M., Mander T., Brennan F.M., Foxwell B.M.J. Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the anti-inflammatory effects of the cytokine. J. Biol. Chem. 271:1996;16357-16362.
38. Buchwald U.K., Geerdes-Fenge H.F., Vöckler J., Ziege S., Lode H. Interleukin-10: effects on phagocytosis and adhesion molecule expression of granulocytes and monocytes in a comparison with prednisolone. Eur. J. Med. Res. 4:1999;85-94.